TM. Dietary fat source alters hepatic gene expression profile and determines the type of liver pathology in rats overfed via total enteral nutrition. Physiol Genomics 44: 1073-1089 , 2012 . First published September 18, 2012 doi:10.1152/physiolgenomics.00069.2012.-To determine if dietary fat composition affects the progression of nonalcoholic fatty liver disease (NAFLD), we overfed male Sprague-Dawley rats low (5%) or high (70%) fat diets with different fat sources: olive oil (OO), corn oil (CO), or echium oil (EO), with total enteral nutrition (TEN) for 21 days. Overfeeding of the 5% CO or 5% EO diets resulted in less steatosis than 5% OO (P Ͻ 0.05). Affymetrix array analysis revealed significant differences in hepatic gene expression signatures associated with greater fatty acid synthesis, ChREBP, and SREBP-1c signaling and increased fatty acid transport (P Ͻ 0.05) in the 5% OO compared with 5% CO group. The OO groups had macrosteatosis, but no evidence of oxidative stress or necrosis. The 70% CO and 70% EO groups had a mixture of micro-and macrosteatosis or only microsteatosis, respectively; increased oxidative stress; and increased necrotic injury relative to their respective 5% groups (P Ͻ 0.05). Oxidative stress and necrosis correlated with increasing peroxidizability of the accumulated triglycerides. Affymetrix array analysis comparing the 70% OO and 70% CO groups revealed increased antioxidant pathways and lower expression of genes linked to inflammation and fibrosis in the 70% OO group. A second study in which 70% OO diet was overfed for 50 days produced no evidence of progression of injury beyond simple steatosis. These data suggest that dietary fat type strongly influences the progression of NAFLD and that a Mediterranean diet high in olive oil may reduce the risk of NAFLD progressing to nonalcoholic steatohepatitis. nonalcoholic steatohepatitis; fatty acid; lipid peroxidation; SREBP-1c; ChREBP NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) is increasingly recognized as a component of "metabolic syndrome," a cluster of pathologies associated with obesity (16). Characterized by initial fat accumulation (steatosis) in up to 70% of obese patients (68), NAFLD pathology can progress to include inflammation, apoptosis, necrosis, and fibrosis (nonalcoholic steatohepatitis, NASH) and ultimately cirrhosis and liver cancer (14). While nutrition and physical activity are clearly major factors in NAFLD development and progression, the exact role of diet composition in this process remains unclear (14, 40).
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) is increasingly recognized as a component of "metabolic syndrome," a cluster of pathologies associated with obesity (16) . Characterized by initial fat accumulation (steatosis) in up to 70% of obese patients (68) , NAFLD pathology can progress to include inflammation, apoptosis, necrosis, and fibrosis (nonalcoholic steatohepatitis, NASH) and ultimately cirrhosis and liver cancer (14) . While nutrition and physical activity are clearly major factors in NAFLD development and progression, the exact role of diet composition in this process remains unclear (14, 40) .
Research in this area has been hampered by lack of an animal model that mimics the natural course and etiological background of NAFLD observed clinically (7, 40) . In general, nutritionally relevant models in which obesity has been achieved as a result of ad libitum feeding of diets high in sugars, such as sucrose and fructose or in saturated fats, have resulted in simple steatosis with limited evidence of progressive injury (37, 52, 69) . Moreover, uncontrolled differences in caloric intake and species and strain differences in response to these diets have resulted in considerable variability in the reported data and difficulties in mechanistic interpretation. These limitations certainly apply to the small number of studies that have examined the role of fat/carbohydrate ratio or the influence of specific fat components on NAFLD/NASH development (5, 11, 13, 15, 33, 35, 56, 72) .
To control diet composition and food intake and to make animals obese by overfeeding, several groups studying NAFLD/ NASH have recently turned to intragastric feeding of liquid diets (7, 8, 18) . We have utilized a variant of this approach: total enteral nutrition (TEN) to develop a new model for NASH in rats overfed a high polyunsaturated fat diet with corn oil as the dietary fat source (7) . In this model, development of hepatic injury was dietary fat-dose and time-dependent, and by 65 days of overfeeding NASH pathology developed similar to that observed clinically, characterized by high levels of oxidative stress, inflammation, and fibrosis (7, 8) . We previously utilized a similar TEN model to examine the effects of diet composition on progression of alcoholic liver injury, which exhibits a very similar overall pathology to NASH (29) . In those studies (29, 58) , we observed that diets high in carbohydrate-to-fat ratio and diets high in saturated fats protected against the development of alcoholic hepatotoxicity, in part as a result of reduced production of reactive oxygen species (ROS) by the enzyme CYP2E1 and in part as a result of reduced susceptibility of hepatic lipids to peroxidation. These data were similar to those previously published by Nanjii and coworkers (43, 44, 49) , suggesting a strong correlation between the degree of unsaturation of dietary fatty acids (FA) and severity of alcoholic liver injury.
The current study was undertaken to determine if similar relationships exist between dietary fat/carbohydrate ratio and the type of fat in the development of NAFLD/NASH. We utilized the TEN model to overfeed male Sprague-Dawley rats isocaloric diets containing three fat sources that differed in their degree of saturation. This was achieved using olive oil (OO, monounsaturated, mainly 18:1); corn oil (CO, polyunsat-urated, mainly 18:2), or echium oil (EO, highly polyunsaturated, mainly 18:3) a plant based omega-3 FA source derived from Echium plantagineum (Viper's bugloss) (10, 76 ) for 3 wk. The analysis included body composition, changes in plasma lipids and metabolic hormones, liver pathology, hepatic gene expression profiles, and lipid composition.
MATERIALS AND METHODS
Experimental animals and diets. Male Sprague-Dawley rats (175 g) were purchased from Harlan Sprague-Dawley (Indianapolis, IN). Animals were housed in an Association for Assessment and Accreditation of Laboratory Animal Care-approved animal facility. Animal maintenance and experimental treatments were conducted in accordance with the ethical guidelines for animal research established and were approved by the Institutional Animal Care and Use Committee at the University of Arkansas for Medical Sciences. Rats had an intragastric cannula surgically inserted and were allowed 7 days to recover before infusion of TEN diets as described previously (7) . Animals had ad libitum access to water throughout the experiments.
In experiment 1, rats were randomly assigned to groups of n ϭ 5-6 and were fed 220 kcal/kg 3/4 /day diets containing 5 or 70% OO, CO, or EO for 21 days. Fat was isocalorically substituted for carbohydrate calories as described previously such that 5% fat diets contained 76% carbohydrate and 70% fat diets contained 11% carbohydrate in the form of 1:3 maltodextrin-dextrose (7, 8) . There were six diets, and each had a caloric density of 890 kcal/l (isocaloric). Protein content (19% in the form of whey) and vitamin and mineral content were the same in all diets (7) . Diets were formulated to meet the caloric and nutritional recommendations established by the National Research Council but were fed at a level that exceeded the recommended caloric intake by 17% to increase weight gain and adiposity and produce steatohepatitis. Body weight gains were measured twice a week and at the beginning and end of the study. Total body fat composition was assessed by nuclear magnetic resonance (Echo, Houston, TX). Rats were killed between 0800 and 1000. Serum and livers were collected and stored at Ϫ20°C and Ϫ70°C, respectively. In experiment 2, n ϭ 10 male rats were fed a pelleted AIN-93G control diet ad libitum and compared with n ϭ 6 male rats, which were overfed the same 70% OO diet used in experiment 1 via TEN for 50 days.
Pathological evaluation. Liver pathology was assessed by hematoxylin-eosin and oil red O staining of liver sections. Oil red O was quantified by image analysis as described previously (7) . Necrosis was assessed biochemically by measurement of serum alanine amino transferase (ALT) activity at death with the Infinity ALT liquid stable reagent (Thermo Electron, Waltham, MA) according to manufacturer's protocols. Apoptosis was assessed by in situ end labeling of free 3=-hydroxyl ends generated during apoptosis (TUNEL) and hepatocyte proliferation was measured by immunohistochemical staining for proliferating cell nuclear antigen (PCNA) as described previously (59) . In experiment 2, liver pathology was scored in blinded samples by a board certified pathologist (L. Hennings). The pathology calculation was as described previously (7) .
Biochemical analysis. Liver lipid peroxidation (thiobarbituric acid reactive substances, TBARS) was assessed as a measure of oxidative stress as described by Ohkawa et al. (45) . Lipid FA profile analysis of liver homogenates was conducted by GC-MS as previously described in our laboratory (74) . Peroxidizability index of liver free FA, triglycerides, and phospholipid fractions was calculated based on FA profiles as described by Lambert et al. (30) . Analysis of liver hydroxecoisatetraenoic acid (HETE) and hydroxyoctadecadienoic acid (HODE) FA metabolites and breakdown products was carried out by HPLC-MS/MS as described previously (75) .
Western blot analysis of protein expression. Western immunoblots were performed against sterol regulatory element binding protein (SREBP)-1c, fatty acid synthase (FASN), acyl CoA carboxylase 1 (ACC), phospho-ACC, and CD36 as previously described and normalized to GAPDH (42, 60 -64) . Western immunoblots against phosphorylated and total mitogen-activated protein (MAP) kinases ERK, p38, and JNK were also performed as described previously (63, 64) . Western immunoblot analysis of apoprotein expression for CYP2E1 and CYP4A1 was conducted as previously described and normalized against total protein loaded based on Coomassie blue staining of whole lanes (60) . CYP2E1 was a gift from the laboratory of Dr. Magnus Ingelman-Sundberg (Karolinska Institute, Stockholm, Sweden) (25) . CYP4Al was detected using a polyclonal sheep antibody to rat CYP4A1 (70) , which was a gift from Dr. Gordon Gibson (University of Surrey, Guilford, UK). Nuclear extracts were prepared and nuclear SREBP-1c expression immunoquantified as previously described (63) . Expression of the transcription factor, carbohydrateresponsive element binding protein (ChREBP) in nuclear extracts was detected in Western immunoblots with a goat polyclonal antibody raised against the COOH terminus of human ChREBP, which cross reacts with the rat form (Santa Cruz Biotechnology Sc-21189). Expression of the early growth response protein-1 (Egr-1) was detected in Western blots of whole liver homogenates using rabbit polyclonal antibody Sc-110 from Santa Cruz Biotechnology. Expression of SREBP-1c, ChREBP, and Egr-1 proteins was normalized against total protein loaded based on Amido black staining of whole lanes.
Hepatic gene expression analysis. Hepatic gene expression profiles were assessed using Affymetrix RGU34A GeneChip microarrays (Affymetrix, Santa Clara, CA) containing 8,800 genes, with ϳ7,000 full-length transcripts and 1,800 expressed sequence tag sequences. Livers were analyzed from rats fed 5 or 70% OO or CO diets, respectively. Total RNA was extracted and three pools prepared from each treatment group, each pool from n ϭ 1-2 livers. The intensity values of different probe sets (genes) generated by Affymetrix GeneChip Software were imported into GeneSpring version 11.0.2 software (Silicon Genetics, Redwood City, CA) for data analysis. The data files (CEL files) containing the probe level intensities were processed by the robust multiarray average algorithm for background correction, normalization, and log transformation of perfect match probe level values (64) . Subsequently, the data were subjected to per-chip and per-gene normalization using GeneSpring normalization algorithms. For comparison analysis, genes were filtered based on minimum 1.5-fold ratio change and P value Յ 0.05 by Student's t-test. Features were classified with connectivity-based clustering with correlation as a distance. Visualization of data was accomplished with GeneSpring GX v11.0.2. Known biological functions of genes were queried and acquired from Affymetrix online data analysis resource NetAffx and gene ontology (GO) analyses performed using Affymetrix GO Browser (64) . Analysis of genes mapped to biological pathways was conducted using Affymetrix NetAffx and GO analysis for biological/molecular function performed with GeneSpring using false discovery rate corrected P Ͻ 0.1 (default for GeneSpring) (64) . Furthermore, the list of genes affected in the liver by OO vs. CO feeding at 5 or 70% calories was analyzed with DAVID to perform Functional Annotation clustering and using Gene Set Enrichment Analysis. This analysis included identifying top interacting networks based on gene data bases from the known literature as described previously for other mRNA data sets (64) . Confirmation of microarray gene expression data was done by real-time RT-PCR.
Real-time reverse transcription-polymerase chain reaction. Total RNA was extracted from livers and adipose tissue with TRI Reagent and cleaned with RNeasy mini columns (Qiagen, Valencia, CA). RNA quality was ascertained spectrophotometrically (ratio of A260/A280) and also by checking ratio of 28S to 18S ribosomal RNA with the RNA Nano Chip on a 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). Total RNA (1 g) was reverse transcribed with the iScript Reverse Transcription kit (Bio-Rad Laboratories, Hercules, CA) according to manufacturer's instructions. The reverse transcribed cDNA (10 ng) was utilized for real-time PCR using the 2ϫ SYBR green master mix and monitored on a ABI Prism 7000 sequence detection system (Applied Biosystems, Foster City, CA). Gene-specific probes described previously (7, 8, 42, 60 -64) position (Ϫ150) of the fatty acid synthase (FASN) promoter were synthesized by Integrated DNA Technologies, (Coralville, IA). Nuclear proteins (3 g) were incubated in reaction buffer containing 10 mM Tris·Cl, pH 7.5, 50 mM NaCl, 1 mM MgCl 2, 0.5 mM EDTA, 0.5 mM DTT, 4% glycerol, and 0.05 mg/ml of poly (dI-dC) with or without 50-fold excess of unlabeled probes and 1.75 pmol of labeled probe for 20 min at room temperature. The complexes resolved with a native 4% polyacrylamide gel in Tris-borate-EDTA buffer for 2 h at room temperature. The gels were dried and exposed to X-ray film for 24 h at Ϫ70°C. SREBP-1 binding activity in 30 g of liver nuclear extracts was determined with the SREBP-1 TransAM kit (Active Motif, Carlsbad, CA) according to the manufacturer's instructions.
Statistical analysis. Data for continuous outcomes are presented as means Ϯ SE. Two-factor analysis of variance (ANOVA) was used to compare mean effects of fat source (oil type), percent fat in diet (5 and 70%), and their interaction on each outcome. Post hoc comparisons of fat source and of percent fat within oil were performed by an all-pairs Tukey-Kramer comparison test and considered significant if P Ͻ 0.05. Statistical analyses were performed with the Stata statistical package version 12.0 (Stata, College Station, TX).
RESULTS

Effects of dietary fat-carbohydrate ratio and fat type on body weight and adiposity.
Comparison among rats overfed diets with three different fat sources (CO, OO, EO) and two levels of fat (5 or 70% of total calories) in experiment 1 revealed no significant group differences in final body weight (323-347 g) or weight gain (3-4 g/day). Moreover, no significant differences were observed in adiposity between the diet groups with % body fat mass ranging from 16 to 18%. In addition, there were no significant effects of altering fat-carbohydrate ratio or fat type on expression of the inflammatory markers tumor necrosis factor-␣ or IL-6 mRNAs in adipose tissue after this short period of overfeeding (data not shown). Collectively these data suggest that, at least over short periods of overfeeding, body composition is not sensitive to changes in dietary macronutrient composition and that in these young rapidly growing animals significant expansion of adipose tissue mass after overfeeding occurs without accompanying inflammation. Data are means (SE) g/g liver. Liver fatty acid composition data from experiment 1 in which rats were overfed 5 or 70% fat diets of different fat composition via total enteral nutrition for 21 days. Means with * were significantly different with different % dietary fat, 5% vs. 70%, P Ͻ 0.005. Means with differing letters are significantly different based on FA type within the same dietary %, P Ͻ 0.005; a Ͻ b.
Effects of dietary fat-carbohydrate ratio and fat type on serum parameters.
Increasing dietary fat content from 5 to 70% of calories elevated fasting glucose concentrations irrespective of FA type (P ϭ 0.002) ( Table 1 ). In contrast, no effects of either carbohydrate-fat ratio or fat type were observed on serum insulin concentrations in these overfed animals. Increasing dietary fat content significantly increased both serum triglyceride and serum NEFA concentrations (P Ͻ 0.005) in the 70% OO and EO groups but failed to do so in the 70% CO group. Serum leptin values were unchanged between groups (Table 1 ). In contrast, overall ANOVA analysis demonstrated that increasing dietary fat concentration decreased serum adiponectin concentrations (P Ͻ 0.0001). However, this only reached statistical significance in the rats fed polyunsaturated fats (Table 1) . These data are consistent with the development of systemic insulin resistance after overfeeding of high-fat diets irrespective of fat type. However, lipid homeostasis and adipokine secretion appear to be sensitive to dietary fat composition.
Effects of overfeeding diets differing in fat content and type on development of NAFLD pathology. Relative liver weight was increased as dietary fat content increased in all groups (P Ͻ 0.05) (data not shown). We assessed appearance of hepatic steatosis by oil red O staining of lipid droplets (Fig. 1) and by measurement of total triglyceride concentrations biochemically (Table 2 ). In general, oil red O staining and triglyceride content increased with dietary fat concentration (P Ͻ 0.002). However, dramatic differences were observed in the nature of the steatosis observed microscopically depending on dietary fat type (Fig. 1) . In groups fed diets containing OO, large lipid droplets characteristic of macrosteatosis predominated. In contrast, in rats fed high CO diets, steatosis appeared to be a mixture of large droplets and small droplets, but only in the 70% group. In rats fed EO diets, all lipid droplets appeared
Corn Oil Olive Oil A B C Fig. 2 . Microarray results for liver from rats overfed high carbohydrate diets containing 5% OO or 5% CO via total enteral nutrition for 21 days. Data are based on analysis using RGU34A GeneChip microarrays of 3 mRNA pools prepared from each treatment group with n ϭ 1-2 livers/pool. A: hierarchical clustering for genes exhibiting Ͼ1.5-fold difference between groups. B: heat map for genes involved in lipid metabolic process. C: pathway analysis of relevant genes expressed at a higher level in the 5% OO group (red) and expressed at a lower level in the 5% OO group (green) relative to the 5% CO group. small (microsteatosis). Interestingly, substantial differences were observed in liver triglyceride accumulation depending on the dietary fat content and type (P ϭ 0.07 for fat type, P ϭ 0.004 for fat type/content interaction). Rats fed 5% OO diets had greater mean triglyceride accumulation than rats fed 5% CO or EO. Increasing dietary fat content to from 5 to 70% resulted in a larger increase in hepatic lipid content in rats in the polyunsaturated fatty acid (PUFA) groups relative to those fed OO ( Table 2) . Assessment of hematoxylin and eosin (H&E)-stained sections did not provide evidence of inflammatory infiltrates or necrotic foci after this short period of overfeeding in any of the diet groups (data not shown). However, serum ALT values were highly dependent on dietary FA dose and composition (P Ͻ 0.0001) ( Table 2 ). The 70% OO group displayed no increase in ALT value relative to the 5% OO group. In contrast, both groups overfed 70% PUFA had abnormally elevated ALTs indicative of cellular necrosis and ALT values followed the order EO Ͼ CO ϾOO (P Ͻ 0.05). In contrast, apoptotic cell death using TUNEL staining was highly variable between 0.1 and 0.4% and was not different between groups (data not shown). At this time point, there was no evidence of increased hepatocyte proliferation in any diet group based on analysis of PCNA immunostaining (Table 2) . Taken together, these data demonstrate that short-term overfeeding of diets high in monounsaturated fatty acids (MUFA) produced macrosteatosis, but no evidence of liver injury. In contrast, overfeeding high-PUFA diets resulted in microsteatosis accompanied by necrotic injury.
Effects of overfeeding diets differing in fat type on FA profiles of hepatic lipids. Comparison of hepatic FA profiles in free FA, triglycerides, and the phospholipid fractions from rats in experiment 1 is shown in Table 3 . In the rats fed low 5% fat diets, hepatic FA composition was relatively similar. Free FAs were predominantly C16:0 and C18:1. Hepatic triglycerides in the low 5% fat groups were composed mainly of C16:0 and C18:1 FA chains. As with the free FA fraction, a small proportion of triglycerides accumulated in the 5% EO group contained 18:3 FAs and the 5% EO group also had detectable C22:6 FAs. In the phospholipid (phosphadylcholine) fraction, the major incorporated FAs after 5% fat overfeeding were 16:0 and 18:0 and arachidonic acid (C20:4). The effects of differing dietary FAs were only observed on minor FA components.
There were no significant effects of increasing dietary fat content from 5% to 70% calories on total hepatic free FA concentrations (Table 3) . However, increasing dietary CO content to 70% increased free levels of C18:2 and arachidonic acid over the 5% CO group (P Ͻ 0.05), while 18:3 levels were elevated in the 70% EO group over the 5% EO group (P Ͻ 0.05). Within the 70% fat groups, 70% CO feeding also increased free 18:2 and arachidonic acid concentration relative to the other two diets. Increasing dietary FA content elevated overall hepatic triglyceride levels (P ϭ 0.0004). This increase was much greater for CO and EO diets than the OO diet (P Ͻ 0.05). FA composition of triglycerides generally reflected dietary FA composition in rats fed 70% fat diets. C18:1 content of triglycerides was increased from 27 to 49% after 70% OO feeding (P Ͻ 0.05); C18:2 content of hepatic triglycerides was increased from 4 to 53% after 70% CO feeding (P Ͻ 0.05). In contrast, increasing dietary EO from 5 to 70% increased 18:2 content of triglycerides from 6 to 43% and increased content of 18:3 FAs from 1.4 to 16% (P Ͻ 0.05). Increasing dietary CO and EO to 70% of calories also increased arachidonic acid content and C22:6 content of hepatic triglycerides (P Ͻ 0.05). Increasing dietary FA content had no effect on overall hepatic phospholipid concentration but produced changes in composition dependent on dietary FA type; C16:0 concentration of phospholipids was lower in 70% fat-fed compared with 5% fat-fed rat livers, and the concentration of C18:0 was greater (P Ͻ 0.05). Within the 70% groups, C18:1 content was higher in the OO group than in the polyunsaturated fat groups, while 18:2 was greater in rats fed 70% CO or EO compared with rats fed 70% OO (P Ͻ 0.05). C18:3 was only found in phospholipid fractions after EO feeding. Taken as a whole, the composition of (Fig. 1, Tables 2 and 3) , we examined potential underlying molecular mechanisms with Affymetrix microarrays to assess global changes in hepatic gene expression between these groups. The original .CEL files have been submitted to the National Center for Biotechnology Information Gene Expression Omnibus (NCBI-GEO) database and are accessible as series record GSE 33166. The gene list generated using a 1.5-fold cut-off is presented in Supplemental Table  S1 . 1 A summary of the gene array data is presented in Fig. 2 . We found 279 genes to be expressed more highly and 126 genes to be expressed at a lower level in the 5% OO group relative to the 5% CO group (Fig. 2A) . Functional annotation clustering by DAVID revealed several clusters of genes involved in lipid homeostasis (Table 4 , Fig. 2B ). This included genes linked to biosynthesis of unsaturated FAs and FA metabolism, several cytochrome P450 enzymes, and genes involved in the peroxisome proliferator-activated receptor (PPAR) signaling pathway. Other major KEGG pathways differing between these groups included genes involved in retinol metabolism, genes linked to the proteosome, and genes associated with antigen processing and presentation (Table 4) . Genes linked to lipid homeostasis included genes encoding FASN, which is rate limiting in de novo FA synthesis from carbohydrates (19) ; CD36 a hepatic FA transporter (39); CYP4A1, involved in FA degradation via -hydroxylation (66); and ApoA4, a lipoprotein associated with VLDL secretion (12) . Real-time RT-PCR was utilized to analyze differences in expression of mRNAs coding for genes involved in FA homeostasis including those revealed by array analysis of OO and CO groups and to further compare them with gene expression in the 5% EO group (Table 5) . Expression of mRNA for three FA transporters, FATP-2, FATP-5, and CD36, was higher in 5% OO group than the 5% CO group (P Ͻ 0.05). In addition mRNA for enzymes controlling FA and triglyceride synthesis, FASN, ACC, and steroyl CoA desaturase (SCD-1), were also higher in the 5% OO group (P Ͻ 0.05). However, greater expression was also noted in mRNAs for PNPLA3 (adiponutrin), implicated in triglyceride hydrolysis, and mRNAs for two proteins involved in VLDL secretion, mitochondrial triglyceride transport protein (MTP), and ApoB-100 in the 5% OO group. Pathways analysis of the array data suggested that higher CD36 in the 5% OO group might be linked to increased expression of two MAP kinases MAPK14 (p38-␣) and MAPK1 (ERK-2) (Fig. 2C) . However, CD36 expression is also regulated via PPARs, and changes in PPAR signaling genes was also indicated in DAVID analysis of the array data (Table 4 ). Higher mean expression of FASN, ACC, and CD36 in liver from 5% OO-fed rats compared with the 5% CO group was confirmed at the protein level by Western immunoblotting (Fig. 3) . Since FASN and ACC are known targets of the transcription factor ChREBP, we measured ChREBP protein in nuclear extracts. ChREBP expression was significantly higher in nuclear extracts from 5% OO-fed compared with 5% CO-fed rats (P Ͻ 0.05) (Fig. 3) . FASN, ACC, and SCD-1 are also all known targets for the transcription factor SREBP-1c. SREBP-1c expression at the mRNA level 1 The online version of this article contains supplemental material. Fig. 3 ). Mean SREBP-1c mRNA values were higher and nuclear SREBP-1c protein levels were greater (P Ͻ 0.05) in the 5% OO-compared to 5% CO-fed group. Since SREBP-1c signaling can be regulated by posttranscriptional modifications such as acetylation (51) and via interactions with coactivators (6, 35), we also examined DNA binding of SREBP-1c to its response element using TransAM ELISA and by EMSA with the consensus SREBP-1c binding site on the FASN promoter (Fig. 4) . Higher SREBP-1c promoter binding was observed in 5% OO rats compared with 5% CO rats in both assays. EMSA specificity was established by competitive binding with unlabeled probe and unrelated sequences. Higher SREBP-1c binding in the 5% OO group in the EMSA was accompanied by significantly reduced migration of the nuclear protein complex, indicating the binding of additional coactivators at this site relative to nuclear extracts from 5% CO rats. One possible coactivator of SREBP-1c signaling is the peroxisome proliferator-activated receptor ␥ coactivator (PGC-1␤, Ref. 35) . Interestingly, relative mRNA expression of PGC-1␤ was higher in the 5% OO-fed compared with 5% CO-fed group: 0.72 Ϯ 0.08 vs. 0.28 Ϯ 0.04 (P Ͻ 0.05).
Despite the 5% EO group also having significantly less steatosis relative to the 5% OO group (Table 2) , fewer differences were observed between the 5% OO and 5% EO groups relative to the differences seen between 5% OO and 5% CO groups in expression of mRNAs of genes involved in FA synthesis or in expression of FASN or ACC proteins. (Table 4 , Fig. 3 ). In addition, although nuclear ChREBP expression was comparable between 5% CO and 5% EO groups, and both were lower than expression in the 5% OO group (P Ͻ 0.05), SREBP-1c nuclear protein levels were more similar in 5% OO and 5% EO groups (Fig. 3) . However, like the 5% CO group, the 5% EO group had significantly less expression of CD36 protein (P Ͻ 0.05) (Fig. 3) . Moreover, PPAR␣ mRNA and expression of mRNAs downstream of PPAR␣ signaling linked to FA degradation (CPT and ACO) were expressed at higher levels (P Ͻ 0.05) in the 5% EO group compared with the 5% OO group (Table 5 ). These differences in FA transport and degradation may contribute to the reduced level of triglyceride accumulation after feeding 5% EO.
These data indicate that the effects of dietary fat type on FA homeostasis are complex and differences in hepatic fat accumulation represent the sum of many different pathways controlling FA import and export, synthesis, and degradation.
Effects of dietary fatty acids on progression of liver injury beyond simple steatosis. In experiment 1, increasing dietary fat content to 70% calories further increased hepatic triglyceride content in all three groups over the 5% fat groups (P Ͻ 0.0005, Tables 2 and 3 ). Gene expression analysis and Western blotting ( Fig. 3 , Table 5 ) suggest that this occurred despite significant reductions in de novo FA synthesis particularly in the 70% OO and 70% EO groups. Suppression of FASN, ACC, and SCD-1 in the 70% OO vs. 5% OO group coincided with decreases in nuclear ChREBP and SREBP-1c expression (P Ͻ 0.005) (Fig.  3) . Whereas reduced FA synthesis in the 70% EO group compared with 5% EO group occurred independently of changes in SREBP-1c expression and despite increased expression of ChREBP-1c (Fig. 3) . In part, the increased steatosis after overfeeding 70% fat diets can be explained by increases in FA transport. Elevating OO from 5 to 70% increased expression of FATP-2 mRNA (P Ͻ 0.05), while increasing CO from 5% to 70% dramatically increased expression of CD36 mRNA and protein (P Ͻ 0.05). In addition, increasing fat content reduced expression of PNPLA3 (adiponutrin) mRNA (P ϭ 0.001). The protein encoded by PNPLA3 has been suggested to be involved in triglyceride hydrolysis, and inactivating mutations in PNPLA3 have been observed clinically in NAFLD patients (63) . Coincident with increased steatosis, increasing dietary fat content increased expression of mRNA encoding adipophilin, a fat droplet associated PAT protein (P Ͻ 0.05). mRNA encoding another PAT protein perilipin was below detection in all treatment groups (data not shown).
Since serum ALT values indicated significant differences in hepatic necrosis between groups overfed 70% fat of different types for 21 days, we examined other aspects of progression of liver injury beyond simple steatosis in these rats. Two sources of ROS formed during FA metabolism are the cytochrome P450 enzymes CYP2E1 and CYP4A1 (2, 7, 36, 61) . Similar to our previously published data with CO diets in the TEN model (7), increasing dietary fat content from 5 to 70% raised expression of CYP2E1 two-to threefold and CYP4A1 four-to sixfold (P Ͻ 0.05) in all three groups independently of dietary fat type (data not shown).
Another suggested component involved in progression of liver injury is increased signaling through the MAP kinase JNK as a result of direct lipotoxicity of circulating NEFA and consequent development of endoplasmic reticulum stress (23, 72) . We analyzed expression of total and phosphorylated JNK, p38, and ERK in whole liver cell lysates from these livers. No phosphorylation of either p38 or JNK was detected in any of the livers from any of the groups. In contrast, total ERK protein expression appeared elevated by 70% fat feeding independent of fat type, and the overall ratio of phosphorylated to total ERK was reduced (P Ͻ 0.05) (data not shown).
Calculation of peroxidizability index of hepatic lipid fractions in the current study demonstrated increased peroxidizability of hepatic free FAs and particularly triglycerides after overfeeding of 70% CO and EO (P Ͻ 0.05), but not after overfeeding with 70% OO (Fig. 5) . In contrast, no differences were observed between peroxidizability of the phospholipid fractions after 70% fat overfeeding. These differences in susceptibility of cellular lipids to attack by ROS were paralleled by similar effects in the hepatic concentration of TBARS depending on dietary fat concentration and type (Fig. 5) . Recent clinical studies of NAFLD and NASH patients have linked specific oxidized FA products to progression of liver injury and NASH. We measured the spectrum of HODE and HETE metabolites in the rat livers from the current study. The data are shown in Figs. 5 and 6. Both 9-and 13-HODE concentrations were dependent on dietary fat concentration and type (P Ͻ 0.05). Both metabolites were elevated by 70% CO or EO (P Ͻ 0.05) but were not increased in the 70% OO group (Fig. 5) . Similarly, 8-and 12-HETE concentrations were increased by overfeeding of 70% CO and EO (P Ͻ 0.05), but not by overfeeding 70% OO. In contrast, 5-HETE concentrations were not significantly different between groups. 11-HETE concentrations were only increased after 70% EO feeding (P Ͻ 0.05). Overall 15-HETE concentrations were increased by 70% fat diets, including 70% OO (P Ͻ 0.05). However, within the 70% groups, the highest mean concentration was with 70% EO (Fig. 6) . Fig. 4 . Analysis of SREBP-1c binding to the FASN promoter in livers from rats overfed 5% OO or 5% CO via total enteral nutrition for 21 days. A: Trans-AM assay; data are means Ϯ SE for assays using 3 nuclear extract pools prepared from each treatment group with n ϭ 1-2 livers/ pool. B: electrophoretic mobility shift assay with hepatic nuclear extracts. Lanes represent 3 nuclear extract pool prepared from each treatment group with n ϭ 1-2 livers/pool.
To examine the differences between the 70% CO and 70% OO groups in experiment 1 at the level of global patterns of hepatic gene expression, we conducted Affymetrix gene array analysis. The original .CEL files have been submitted to NCBI-GEO database and are accessible as series record GSE 33166. The gene list generated using a 1.5-fold cut-off is presented in Supplemental Table S2 . A summary of the gene array data is presented in Fig. 7 . We found 212 genes to be expressed more highly and 134 genes to be expressed at lower levels in the 70% OO group relative to the 70% CO group (Fig.  7A) . Functional annotation clustering with DAVID (Table 4) revealed many of the same gene clusters identified in the comparison of 5% OO and 5% CO groups: top KEGG pathways included fatty acid metabolism, retinol metabolism, PPAR signaling, and cytochrome P450 expression. However, in addition, unique gene clusters that differed only in the 70% fat groups included those involved in arachidonic acid metabolism, the immune response (B and T cell receptor signaling), Toll-like receptor signaling, chemokine signaling, adipokine signaling, and MAP kinase signaling. Hierarchical clustering and pathways analysis are shown in Fig. 7 , B and C. In agreement with the real-time RT-PCR data shown in Table 5 , we observed greater expression of genes encoding proteins involved in FA synthesis (FASN), FA degradation (ACOX, HADHA, CYP4A1), and VLDL formation (ApoB) in the 70% OO group compared with the 70% CO group. Compared with the 70% CO group, CYP3A1/23, CYP2C7, CYP2C37, and CYP1A2 were expressed to a greater degree in the 70% OO group, while CYP2B3 was lower. Interestingly we observed higher expression of genes involved in antioxidant defense in the 70% OO group, e.g., Gsr (glutathione reductase), Nqo1 (quinine oxidoreductase), and Sod1 (superoxide dismutase) (Fig. 7C) and have confirmed some of the differences in relative mRNA expression by real-time RT-PCR: Gsr 14.7 Ϯ 4 vs. 7.5 Ϯ 0.8, Nqo1 15.1 Ϯ 3 vs. 9.3 Ϯ 2.3 (70% OO vs. 70% CO). In contrast, hierarchical clustering and pathways analysis revealed that a variety of mRNAs for genes linked to hepatic inflammation and fibrosis were expressed at higher levels in the 70% CO group than the 70% OO group (Fig. 7, B and C) . These included: angiotensinogen (Agt), the precursor of angiotensin II (27) ; RhoA (27) ; the cytokine IL-18 (71); the chemokine Ccl5 (28, 33) ; and Egr-1 (53) . Relative expression of mRNA encoding the pregnancy zone protein (pzp), suppression of which has been linked to cirrhosis (34) , was reduced by 70% CO, and this was confirmed by real-time RT-PCR (7.2 Ϯ 1.5 vs. 14. 8 Ϯ 3.8, 70% CO vs. 70% OO). We confirmed the increase in Egr-1 expression in the 70% CO group at the protein level by Western blot (Fig. 7D) .
We have previously demonstrated that TEN overfeeding of CO diets, administered for longer periods, resulted in dose-and time-dependent progression of liver injury from simple steatosis to complete NASH (7, 8) . To determine if longer overfeeding of the 70% OO resulted in progression of liver pathology to NASH, in experiment 2 we compared liver pathology after TEN overfeeding of the 70% OO diet for 50 days with baseline liver pathology in a group of male rats fed a pelleted AIN-93G diet ad libitum. The results are shown in Fig. 8 . Although the total liver pathology score was greater in the 70% OO overfed (28) for free fatty acids, triglycerides, and phospholipids extracted from liver based on quantitation of fatty acid composition shown in Table  6 . Bottom: lipid peroxidation in whole liver homogenates measured according the method of Ohkawa et al. (42) 8D . Although small increases were observed in CD68/CD45 mRNA ratio and SMA expression in the OO group compared with controls (P Ͻ 0.05), there was no consistent molecular evidence for increased inflammation, stellate cell activation, or fibrosis even after this much longer period of 70% OO overfeeding. These data indicate that despite high levels of steatosis in all animals overfed high-fat diets, progression of liver injury was only evident after overfeeding PUFA and that this was linked to lipid peroxidation.
DISCUSSION
Although extensive research has been conducted on the development of NAFLD and the progression to NASH in animal models, the relevance to obesity-related NASH is not clear. For example, genetic modification and dietary deficiency models, such as the methionine-choline deficient model, result in hepatic lipid accumulation and robust pathology in the absence of obesity (1, 21, 24, 31, 32, 33, 57, 65, 68) . Studies that have used ad libitum consumption of diets high in saturated fats or simple carbohydrates, show development of NAFLD but suffer from lack of much progression of injury beyond simple steatosis despite long feeding periods and are complicated by differences in caloric intake (52, 56, 69) . The current study employed a previously reported model in which isocaloric liquid diets of differing composition are used to overfeed male rats via total enteral nutrition (7) . Using this model, we previously demonstrated that overfeeding a diet high in CO, a source of predominantly 18:2, -6 PUFA, could produce NASH pathology in 9 wk (7, 8) .
Most dietary NASH studies have utilized long-chain saturated fats as part of solid high-fat diets (1, 13, 56, 72) . The role of macronutrient composition in NAFLD development remains an area of considerable disagreement between investigators (1, 7, 13, 15, 30, 35, 40, 56, 72) . Studies of alcoholic liver injury, which is pathologically very similar to NAFLD/NASH, have suggested that both short-and long-chain saturated FA diets are protective against development of both steatosis and progression of injury and that the more unsaturated the dietary fatty acid, the more severe the liver injury (43, 44, 49) . However, only a relatively small number of studies have examined the effects of dietary fat composition on development of NAFLD.
Liver pathology differed dramatically with dietary fat content and type. For example, in the 5% fat, high carbohydratediet groups, the CO and EO diets produced low levels of steatosis relative to 5% OO. In the 5% CO group, this appeared to reflect lower levels of FA import and a lower rate of FA synthesis. Supplementation of high carbohydrate diets with oils like CO, which are rich in -6 PUFAs have previously been shown to result in reduced expression of a large number of lipogenic genes such as FASN and ACC (19, 20, 26 Microarray results for rats exposed to 70% OO and 70% CO via total enteral nutrition for 21 days. Data are based on analysis using RGU34A GeneChip microarrays of 3 mRNA pools prepared from each treatment group with n ϭ 1-2 livers/pool. A: hierarchical clustering for genes exhibiting Ͼ1.5-fold change, B: heat map for genes involved in metabolic redox process. C: pathway analysis of relevant genes expressed at a higher level in the 70% OO group (red) and expressed at a lower level in the 70% OO group (green) relative to the 70% CO group. D: Western blot and immunoquantitation of hepatic Egr-1 protein expression comparing 70% OO and 70% CO groups, * P Ͻ 0.05.
part of the effect of CO appears to be due to reduced nuclear expression of the transcription factor ChREBP, which is a positive regulator of lipogenesis. This is consistent with studies from Dentin et al. (20) demonstrating inhibition of ChREBP signaling and nuclear translocation in carbohydrate-fed mice fasted for 24 h and then switched to a diet high in linoleate. Consistent with previous studies suggesting -6 PUFAs also interfere with SREBP-1c gene transcription and proteolytic processing (11, 17, 31) , in the current study we observed that dietary CO reduced nuclear SREBP-1c protein concentrations and binding to the FASN promoter in the 5% diets relative to 5% OO. These data suggest that differences in FA synthesis can also be attributed to possible effects of CO on SREBP-1c activation and recruitment of coactivators to the SREBP-1c response element. SREBP-1c has been shown to undergo extensive posttranslational modifications including phosphorylation, acetylation, and sumoylation, which can alter its transcriptional activity (4, 9, 51) . In addition, several SREBP-1c coactivators have been identified, including the Sp1 protein family and PGC-1␤ (6, 32) . We observed higher expression of mRNA encoding PGC-1␤ in the 5% OO compared with 5% CO group. However, detailed examination of the effects of FA type on SREBP-1c signaling and the potential role of PGC-1␤ in this process will require additional studies. The signaling mechanisms underlying such large differences in ChREBP and SREBP-1c signaling and hepatic FA homeostasis produced by variations in the FA composition of only 5% of the diet remain unclear. Array analysis suggested that differences in MAP kinase-mediated phosphorylation patterns or changes in PPAR or retinoid signaling pathways may play a role. In addition, FAs themselves, their thiolesters and oxidation products produced by the action of cytochrome P450, cyclooxygenase, and lipoxygenase enzymes, have all been suggested to act as signaling molecules regulating gene transcription (17, 24, 26, 57) . A dramatic increase in expression of the FA transporter CD36 was observed in the 70% CO group compared with the 5% CO group, consistent with our previous observations using CO in this model (7) . As a result of this, hepatic triglyceride accumulation was similar between FA sources with overfeeding at 70% calories. However, despite similar levels of triglycerides, the type of steatosis produced differed dramatically. Rats overfed OO had macrosteatosis, rats overfed CO had mixed macro-and microsteatosis, and rats overfed EO had only microsteatosis. The mechanisms underlying the differences in lipid droplet size remain obscure. Although the PAT protein, perilipin, has been reported to influence droplet size (46), perilipin was not detected in the current study. Since the proportions of different FAs incorporated in hepatic triglycerides reflect the composition of FAs in dietary fat (31, 32, 74) , it is possible that the physical stability of hepatic lipid droplets composed of triglycerides with FA chains composed mainly of MUFA is greater than that of lipid droplets composed of triglycerides with FA chains composed mainly of PUFA. The end result is smaller lipid droplets with an overall increase in surface area in 70% EO fed rats compared with the 70% CO-fed and 70% OO-fed groups.
Progression of injury beyond simple steatosis appeared to be mainly linked to the susceptibility of free FAs and FAs incorporated into lipid droplets to radical attack. Even though high-fat diets increased expression of CYP2E1 and CYP4A1, which are sources of ROS, to the same degree, elevated serum ALT values representative H&E-stained 70% OO liver (ϫ10). C: pathology scores for inflammation ϩ necrosis, lipidosis, and total pathology. Data are means Ϯ SE for n ϭ 10 control and n ϭ 6 70% OO livers, *P Ͻ 0.05 OO vs. control. D: mRNA expression in control and 70% OO livers. TNFa, tumor necrosis factor alpha; TGFb, transforming growth factor beta; Col1a3, collagen 1a3; CD45/ CD85, cell surface marker ratio is a measure of leukocyte activation and hepatic infiltration; SMA, smooth muscle actin; PDGFRb, platelet-derived growth factor receptor beta. Data are means Ϯ SE for n ϭ 10 control and n ϭ 6 70% OO livers, *P Ͻ 0.05 OO vs. control.
only occurred in rats fed the PUFA-rich CO diet. Increased necrosis correlated with the calculated lipid peroxidizability index, overall production of lipid peroxidation products as measured by TBARS, and appearance of HODE and HETE products of oxidized PUFA, produced biologically via lipoxygenase enzymes or chemically through radical attack. A similar relationship between increased progressive injury and hepatic accumulation of lipid peroxides was recently observed by Larter et al. (31) in MCD mice fed PUFA-enriched diets made with fish oil relative to MCD mice fed diets supplemented with MUFA in the form of OO. The pattern of hepatic HODE and HETE metabolites of PUFA found in the liver of 70% CO and 70% EO groups with evidence of progressive injury was also similar to that previously reported in clinical studies of serum lipid metabolites from NAFLD and NASH patients (22, 52) . Gene array analysis comparing 70% CO and 70% OO groups suggests that pathways linked to cellular stress and activation of the immune system including increased Egr-1 expression, Toll-like receptor signaling, and chemokine signaling are all elevated following overfeeding of PUFA-rich CO. Activation of these pathways may occur via signaling though PUFA or their metabolites (55, 66) . Alternatively, they may be linked to the biological actions of reactive lipid peroxidation products such as the short-chain aldehydes 4-hydroxynonenal and malondialdehyde (8, 50) . In addition to a lower capacity for accumulated FAs and triglycerides to undergo radical attack, gene array analysis suggested that dietary OO consumption also increased expression of several antioxidant systems. Some of the protective effects of OO on development of oxidative stress and inflammation may result from the presence of other components in addition to MUFA. These include ␣-tocopherol and phenolic antioxidants and phytochemicals such as squalene (4) . Finally, unlike overfeeding of PUFA-rich CO, overfeeding of OO did not significantly suppress serum adiponectin levels. Since adiponectin has been shown to reduce liver injury after consumption of high-fat diets and reduced adiponectin has been linked to development of NAFLD, differences in adipokine signaling may also contribute to the lack of progression of hepatic pathology beyond simple steatosis in these animals (63) .
In conclusion, the fat composition of the diet (as well as the dietary fat-carbohydrate ratio) strongly affects the steatosis phenotype and progression of liver injury. Liver FA composition reflects dietary fat composition, and these FAs or their metabolites appear to regulate gene transcription of hepatic FA transporters, FA synthesis, FA degradation, triglyceride hydrolysis, and VLDL packaging and export. Liver lipid droplets were larger in rats fed MUFA-rich compared those fed PUFArich diets. We speculate the high degree of peroxidizability and the increased surface area of the small hepatic lipid droplets formed in rats fed PUFA-enriched 70% EO diet allowed for increased radical attack, leading to the greatest progressive injury. There was no evidence of progression of injury beyond simple steatosis in rats fed OO, suggesting a hepato-protective effect of MUFAs and potentially of other phytochemical components of OO relative to PUFA-rich oils. These data are consistent with several recent clinical studies demonstrating positive effects of OO-rich Mediterranean diets on NASH symptoms such as ALTs (5, 47) and an overall lower incidence of metabolic syndrome in the Mediterranean region compared with the USA (3).
